Neuromodulation Technologies - A Strategic Perspective (TechVision)
24-Feb-2016
Global
Technology Research
D6D1-01-00-00-00
HC02621-SA-TR_16743
Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. This research service offers a strategic perspective on the industry, analyzing the gaps between technology push-pull factors that are poised to enable OEMs sustain both volume growth and margin. This research also examines how OEMs can shift from a value-to-cost model to a value-to-serve business model, which plays a lead role in delivering personalized value to healthcare payers and care providers.
1.1 Scope of Research
1.2 Research Methodology
2.1 Transferring Cost Efficiencies across the Value Chain
2.2 IP Filings Focus on Minimally Invasive Therapies
2.3 Clinical Trials to Diversify Product Pipeline
2.4 Differentiate Products by Building a Value-driven Organization
3.1 Invasive, Minimally Invasive and Non-Invasive Neuromodulation Technologies
3.2 High Market Demand for Non-Invasive Methods and Therapies for Lifestyle Disorders
3.3 Spinal Cord and Deep Brain Stimulation Systems, Global, 2016
3.4 Vagus Nerve and Other Stimulation Systems, Global, 2016
3.5 NPD Efforts Focus on Miniaturization of Implants
3.6 Objectives of OEMs Are Aligned to Delivering Personalized Value to Payers
3.7 Focus on Creating Effective Collaboration among Payers Drive Channel Growth
3.8 Neuromodulation Systems, Prices, Global, 2016
3.9 Assessment of Components of Neuromodulation Systems
3.10 Analytical Hierarchy Process: Prioritization of Neuromodulation Technologies
3.11 Performance of Pulse Generator and Lead Precision Is of High Priority
3.12 Functionality of Device Controller and Programmer Are of Least Priority
3.13 Improving the Longevity of Power Supplies and Lead Flexibility
3.14 Payer Preference to Minimally Invasive Therapies for Chronic Conditions
4.1 80% of Market Share Is Owned by Four Companies
4.2 Cost-efficient Value Chain and Consolidation Efforts Drive Profitable Growth
4.3 Better Patient-Physician Collaboration Drive Technology Growth
4.4 Consolidation Trends Pull Prospective Investments within the Global Industry
4.5 OEMs Race against VC/PE Firms to Invest in Neuromodulation Technologies
4.6 Increase in Cross-selling Agreements with Pharmaceutical Companies
4.7 OEMs Place a Premium during Commercialization of Co-created Products
4.8 Established Mid-size Firms Are Partnership Targets in Emerging Markets
4.9 Backward Integration Efforts of OEMs Will Deliver Personalized Value
4.10 VC and Major Pharmaceutical Firms Influence Growth in Delivery of Quality Care
5.1 Centricity between Cost Efficiency and Market Maturity Enabled Customer Value
5.2 Neuromodulation: Key Growth Strategies for a Value-Driven Business Model, Global, 2016
5.3 Value-for-Cost Business Model: OEMs Focus on Cost Savings within the Value-Chain
6.1 A Robust Operations Analytics Framework to Drive Quality Patient Care
6.2 Strategic Partnerships Deliver Sustainable Growth and Value Proposition
7.1 Boston Scientific Leads in IP Creation Activities Worldwide
7.2 Key Patents: Cantilever Electrodes for Transdermal and Transcranial Stimulation
7.3 Key Patents: Optogenetic Therapies for Movement Disorders
7.4 Key Patents: Minimally Invasive Implantable Neurostimulation Systems
7.5 List of Key Industry Participants
Legal Disclaimer
8.1 Analytical Hierarchical Process
8.2 Explanation of Benchmarking Criteria
8.3 Liberatore’s Rating Scale
9.1 The Frost & Sullivan Story
9.2 Value Proposition: Future of Your Company & Career
9.3 Global Perspective
9.4 Industry Convergence
9.5 360º Research Perspective
9.6 Implementation Excellence
9.7 Our Blue Ocean Strategy
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.